Assessment of Serum Lactate Dehydrogenase as Early Diagnostic Biomarker in Pregnancy with Preeclampsia and Eclampsia: A Comparative Study
International Journal of Current Pharmaceutical Review and Research · 28.02.2026 · 18 (02)
DOI: 10.25258/ijcpr.18.2.302 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 28.02.2026. Verfasst von Prabha Verma und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Numerous changes in biochemical, physiological, hematological, and immunological processes are related to the physiological state of pregnancy. Six to eight percent of pregnancies are complicated by preeclampsia and eclampsia, which can result in a number of problems for both the mother and the fetus. The current study's objectives were to assess serum LDH levels in both normal pregnant women and pregnant women with preeclampsia and eclampsia during the antepartum phase and to investigate the relationship between serum LDH levels and maternal and perinatal outcomes.
Method
From January 2014 to December 2014, ANC mothers between the ages of 18 and 35 who had term singleton pregnancies and were attending the Obstetrics and Gynecology OPD and labor room at Patna Medical College and Hospital in Patna, Bihar, participated in this prospective study. Relevant laboratory tests were carried out following informed consent and a thorough clinical assessment. A completely automated biochemical analyzer was used to estimate the serum LDH.
Results
A total of 200 pregnant women were included in the study; 100 of them were normal pregnant women who served as the control group; the remaining 34 (17%) instances were pregnancies with eclampsia, and 66 (33%) were pregnancies with pre-eclampsia. Eight (27.6%) of the 29 study group cases with serum LDH levels between 600 and 800 IU/L had severe pre-eclampsia, and eighteen (62.0%) had eclampsia. Of the 34 cases of eclampsia, 18 (52.9%) had serum LDH levels between 600 and 800 IU/L, while 14 (41.2%) had levels greater than 800 IU/L. The study group's mean serum LDH was 570.5 IU/L, while the control group's was 201.5 IU/L. Maternal problems such as abruption, PPH, DIC, and eclampsia with LDH>600 were present in the patients. Neonatal complications like IUGR, fetal distress, neonatal death, LBW, premature birth, IUD were increased with raised LDH.
Conclusion
The first indicator of hypoxia and oxidative stress in the blood is serum LDH. Both pre-eclampsia and eclampsia raise it. In order to reduce maternal and fetal morbidity and death, high-risk individuals with elevated LDH levels must be closely monitored and treated promptly. A predictive indicator for preeclampsia and eclampsia is the measurement of serum lactate dehydrogenase.
Zitieren
APA
Verma, P., Narayan, N., & Sinha, S. (2026). Assessment of Serum Lactate Dehydrogenase as Early Diagnostic Biomarker in Pregnancy with Preeclampsia and Eclampsia: A Comparative Study. International Journal of Current Pharmaceutical Review and Research, 18(02). https://doi.org/10.25258/ijcpr.18.2.302
Vancouver
Verma P, Narayan N, Sinha S. Assessment of Serum Lactate Dehydrogenase as Early Diagnostic Biomarker in Pregnancy with Preeclampsia and Eclampsia: A Comparative Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(02). doi:10.25258/ijcpr.18.2.302
BibTeX
@article{Verma2026,
author = {Verma, Prabha and Narayan, Nutan and Sinha, Sangeeta},
title = {Assessment of Serum Lactate Dehydrogenase as Early Diagnostic Biomarker in Pregnancy with Preeclampsia and Eclampsia: A Comparative Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {02},
doi = {10.25258/ijcpr.18.2.302}
}
EUVIMED